Frank Anderson

6.3k citations

64 papers · 3.7k indexed · 2 hit papers · h-index 23

Hepatology top 0.5%
- Hepatitis C virus research 18
Epidemiology top 1%
- Hepatitis B Virus Studies 12
- Liver Disease Diagnosis and Treatment 9
- Microscopic Colitis 5
Genetics top 1%
- Inflammatory Bowel Disease 6
Immunology top 5%
Surgery top 5%
- Pancreatitis Pathology and Treatment 10
- Pediatric Hepatobiliary Diseases and Treatments 7
Oncology
- Pancreatic and Hepatic Oncology Research 10

Co-authors: Brian G. Feagan Gary Wild Paul Rutgeerts Michael A. Kamm William Y. Chey Jane E. Onken Bruce E. Sands Joshua R. Korzenik
Cited by: Hepatology Epidemiology Genetics
Partner nations: Canada South Africa United States

In The Last Decade

Frank Anderson

62 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
2004 Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Peers

Countries citing papers authored by Frank Anderson

Since Specialization

Citations

This map shows the geographic impact of Frank Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Anderson more than expected).

Fields of papers citing papers by Frank Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Anderson. The network helps show where Frank Anderson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frank Anderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Anderson Line = papers co-authored together Frank Anderson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HIV infection drives interferon signaling within intestinal SARS-CoV-2 target cells Rabiah Fardoos,Osaretin E. Asowata,Nicholas Herbert,Sarah K. Nyquist,Yenzekile Zungu,Alveera Singh,Abigail Ngoepe,Ian Mbano,Ntombifuthi Mthabela,Dirhona Ramjit,Farina Karim,Warren Kuhn,Fusi Madela,Vukani T. Manzini,Frank Anderson,Bonnie Berger,Tune H. Pers,Alex K. Shalek,Alasdair Leslie,Henrik N. Kløverpris	2021	5
2	Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection Osaretin E. Asowata,Alveera Singh,Abigail Ngoepe,Nicholas Herbert,Rabiah Fardoos,Kavidha Reddy,Yenzekile Zungu,Faith Nene,Ntombifuthi Mthabela,Dirhona Ramjit,Farina Karim,Katya Govender,Thumbi Ndung’u,J. Zachary Porterfield,John Adamson,Fusi Madela,Vukani T. Manzini,Frank Anderson,Alasdair Leslie,Henrik N. Kløverpris	2021	15
3	The spectrum of gastric cancer as seen in a large quaternary hospital in KwaZulu-Natal, South Africa F Benamro,Benn Sartorius,Damian Clarke,Frank Anderson,Emil Loots,Lynda Olinger	2017	6
4	Health utilities and psychometric quality of life in patients with early‐ and late‐stage hepatitis C virus infection Priscilla C. Hsu,Carole A. Federico,Mel Krajden,Eric M. Yoshida,Karen E. Bremner,Frank Anderson,Alan Weiss,Murray Krahn	2011	61
5	Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C Ava John‐Baptiste,George Tomlinson,Priscilla C. Hsu,Mel Krajden,E. Jenny Heathcote,Audrey Laporte,Eric M. Yoshida,Frank Anderson,Murray Krahn	2009	72
6	Preduodenal portal vein: a potential laparoscopic cholecystectomy nightmare. Naseem Bhorat,S R Thomson,Frank Anderson	2009	1
7	Does cirrhosis affect quality of life in hepatitis C virus‐infected patients? Priscilla C. Hsu,Mel Krajden,Eric M. Yoshida,Frank Anderson,George Tomlinson,Murray Krahn	2009	24
8	[127] Phil PROOF OF CONCEPT STUDY OF CELGOSIVIR IN COMBINATION WITH PEGINTERFERON o-2b AND RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE-1 NON-RESPONDER PATIENTS K. Kaita,Eric M. Yoshida,Derek Kunimoto,Frank Anderson,Susan Morris,P. Marotta,Linda Scully,Kevork Peltekian,Robert Enns,Francisco Díaz‐Mitoma,S. Lee,Lawrence Worobetz,Jim Pankovich,Ann Katrin Petersen	2007	19
9	Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy Morris Sherman,Eric M. Yoshida,Marc Deschênes,Mel Krajden,Vincent G. Bain,Kevork Peltekian,Frank Anderson,Kelly Kaita,Susan Simonyi,Robert Balshaw,Shoei‐Sheng Lee	2006	65
10	Isolated main pancreatic duct injuries spectrum and management Ines Buccimazza,S R Thomson,Frank Anderson,Namasha M. Naidoo,Damian Clarke	2006	43
11	Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy Norah A. Terrault,Jean–Michel Pawlotsky,John G. McHutchison,Frank Anderson,Mel Krajden,Stuart C. Gordon,Ian M. Zitron,Robert Perrillo,Robert G. Gish,Mark Holodniy,Michel Friesenhahn	2005	21
12	Infliximab Maintenance Therapy for Fistulizing Crohn's Diseasebreakdown → Bruce E. Sands,Frank Anderson,Çharles N. Bernstein,William Y. Chey,Brian G. Feagan,Richard N. Fedorak,Michael A. Kamm,Joshua R. Korzenik,Bret A. Lashner,Jane E. Onken,Daniel Rachmilewitz,Paul Rutgeerts,Gary Wild,Douglas C. Wolf,P Marsters,Suzanne Travers,Marion Blank,S J van Deventer	2004	1607
13	Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection Ching‐Lung Lai,Rosmawati Mohamed,Judy Lao,Hans Van Vlierberghe,Frank Anderson,Neal J. Thomas,Deborah DeHertogh	2002	226
14	Double-blinded, randomized, placebo-controlled trial of the remission inducing and steroid sparing properties of two schedules of ISIS 2302 (ICAM-1 antisense) in active, steroid-dependent crohn's disease Bruce Yacyshyn,W.Y. Chey,J S Goff,Bruce Salzberg,Alan L. Buchman,R H Baerg,Frank Anderson,George Koval,Charles F. Barish,Michael Safdi,P. Rutgeerts,William Shanahan	2000	9
15	ALTERATION OF THE DISMAL NATURAL HISTORY OF FIBROSING CHOLESTATIC HEPATITIS SECONDARY TO HEPATITIS B VIRUS WITH THE USE OF LAMIVUDINE Khalid Al Faraidy,Eric M. Yoshida,Jennifer Davis,Robert K. Vartanian,Frank Anderson,Urs P. Steinbrecher	1997	43
16	Seasonal Change in the Exacerbations of Crohn's Disease Lirong Zeng,Frank Anderson	1996	46
17	ATTEMPTED RESOLUTION OF ACUTE RECURRENT HEPATITIS B IN A TRANSPLANTED LIVER ALLOGRAFT BY THE ADMINISTRATION OF GANCICLOVIR Eric M. Yoshida,Robert Wolber,Wafeeq Mahmood,Frank Anderson,Charles H. Scudamore,Siegfried R. Erb	1994	12
18	Sensitivity and Specificity of Liver Function Tests in the Detection of Parenteral Nutrition‐Associated Cholestasis Amin A. Nanji,Frank Anderson	1985	46
19	Relationship between Serum Albumin and Parenteral Nutrition‐Associated Cholestasis Amin A. Nanji,Frank Anderson	1984	8
20	An atlas of overdentures and attachments Joseph F. Jumber,Michael J. Jumber,Frank Anderson	1981	12

About Frank Anderson

Frank Anderson is a scholar working on Hepatology, Epidemiology and Surgery, having authored 64 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (12 papers), Pancreatitis Pathology and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), Liver Disease Diagnosis and Treatment (9 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers), Inflammatory Bowel Disease (6 papers) and Microscopic Colitis (5 papers). The work is most often cited by research in Hepatology (1.3k citations), Epidemiology (2.3k citations) and Genetics (1.5k citations). Frank Anderson has collaborated with scholars based in Canada, South Africa and United States. Frequent co-authors include Brian G. Feagan, Gary Wild, Paul Rutgeerts, Michael A. Kamm, William Y. Chey, Jane E. Onken, Bruce E. Sands, Joshua R. Korzenik, P Marsters and Daniel Rachmilewitz.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact